Contraception Guidelines
Intrauterine Devices
- The copper IUD (Paragard) is effective for at least 10 years, with potential extended use beyond this timeframe, and has a failure rate of less than 1%, as a hormone-free option for contraception, according to the American College of Obstetricians and Gynecologists 1, 2
- Levonorgestrel IUDs are a highly effective form of contraception, with a failure rate of less than 1%, as reported by the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists 3, 2
- The following IUD types have these durations of approved use:
| IUD Type | Active Ingredient | Duration of Approved Use | |
|---|---|---|---|
| Paragard | Copper | 10 years | |
| Mirena | 52 mg levonorgestrel | 5-7 years | |
| Kyleena | 19.5 mg levonorgestrel | 5 years | |
| Liletta | 52 mg levonorgestrel | 5 years | |
| Skyla | 13.5 mg levonorgestrel | 3 years | [4, 5, 6, 7, 8] |
Contraindications and Precautions
- Contraindications for progesterone IUDs include current purulent cervicitis, active gonorrhea or chlamydia infection, current PID, pregnancy, uterine anomalies that distort the cavity, and decompensated liver cirrhosis, as recommended by the American Association for the Study of Liver Diseases 6, 1
- Certain antiretroviral medications may potentially affect levonorgestrel levels, and women with certain conditions, such as advanced HIV disease, may require more careful monitoring, as recommended by the American Academy of Pediatrics 3
Insertion and Maintenance
- Before IUD insertion, a bimanual and cervical exam should be performed to rule out infections, and STI testing should be considered in women with risk factors, as recommended by the CDC 2
- Proper technique for IUD insertion is essential and includes cleansing the cervix with antiseptic solution, using ring forceps to grasp the anterior lip of the cervix, ensuring high fundal placement of the device, and confirming fundal placement through bimanual examination or ultrasound guidance 4
- A bimanual and cervical examination should be performed to verify the correct position of the IUD and rule out infections, as recommended by the CDC 9
- The Society for Maternal-Fetal Medicine recommends that IUDs should be left in place up to their maximum lifespan and not routinely replaced earlier, minimizing the risk associated with the insertion process 4
Benefits and Risks
- Progesterone IUDs can provide significant reduction in menstrual bleeding, improvement in dysmenorrhea, and can be used for non-contraceptive benefits such as treatment of heavy menstrual bleeding, with rapid return to fertility after removal 7
- The risk of pelvic inflammatory disease (PID) is higher in the first 20 days after IUD insertion, and after this initial period, the additional risk of PID in IUD users, if it exists, is small, according to the CDC 2
- IUDs do not protect against sexually transmitted infections (STIs) or HIV, as stated by the CDC, and consistent condom use should be recommended in women with IUDs who are at risk of STIs/HIV 2
Special Populations
- For perimenopausal women, levonorgestrel-releasing IUDs can be beneficial when combined with estrogen therapy for management of menopausal symptoms, with timely replacement at 5 years remaining important to maintain both contraceptive efficacy and endometrial protection, according to the American College of Obstetricians and Gynecologists 4
- The Society for Maternal-Fetal Medicine recommends LNG-IUDs for women at high risk for medical complications 4